Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19965662 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety Study or Fostamatinib Disodium Tablets to Treat B-cell Lymphoma
Condition: Lymphoma
Intervention: Drug: Fostamatinib Disodium

Indicates status has not been verified in more than two years